CMS Billing Code Changes Could Impact Biosimilars' Competitiveness With Reference Products - The Center for Biosimilars

The Center for BiosimilarsCMS Billing Code Changes Could Impact Biosimilars' Competitiveness Wit

» » CMS Billing Code Changes Could Impact Biosimilars' Competitiveness With Reference Products - The Center for Biosimilars , ago, 38 view
Subscribe to our Facebook Bot


The Center for Biosimilars

CMS Billing Code Changes Could Impact Biosimilars' Competitiveness With Reference Products
The Center for Biosimilars
The proposed CMS rule change could give every biosimilar its own Healthcare Common Procedure Coding System (HCPCS) (?J-code?). Currently, Medicare Part B pays for biosimilars under the Physician Fee Schedule (PFS) based on average sales price ...


Read more

2017-10-31T04:20:08Z 250250
Dragplus